An international consultancy providing services to measure the benefit and clinical value of medical products using clinical outcome assessments.
Joined December 2017
- Tweets58
- Following24
- Followers75
- Likes2
In our recently published co-authored Open Access paper, we present #ConceptDrivenMeasurement analyses of clinical trial data, including legacy fatigue PROs: link.springer.com/article/10…
Our findings highlight the importance of matching context-of-use to concept-of-interest, and will help inform future studies.
#Lupus #PatientCenteredOutcomes
At #EHA2021, @ModusOutcomes is presenting a landscape review, which includes a series of graphical displays, applied to real clinical trial data, to illustrate how #PROCTCAE data can be used to gain a better understanding of the patient experience of symptomatic toxicities.
At #MADID2021, @ModusOutcomes will present the findings of a qualitative study, conducted in partnership with @Regeneron, considering the heretofore unexplored symptoms and daily life impacts of #COVID19 on outpatients.
#PatientCenteredOutcomes #QualitativeResearch
#NUTCarcinoma is a rare, highly aggressive cancer, in which little is known about the patient experience. At Virtual @ISPORorg 2021, @ModusOutcomes is presenting a qualitative research study which aimed to better understand the symptoms and impact of NUT Carcinoma on patients.
This research provides an evidence base to inform patient-centered outcome benefit demonstration in future clinical trials in this cancer.
#PatientExperience #RareCancer #ISPORAnnual #Oncology
The rare disease treatment trial session was a highlight of this week’s @CPathInstitute PRO Consortium Workshop. If you are interested in getting on track with your PCO strategy, you may be interested in our co-authored paper with @DrThomasMorel: ojrd.biomedcentral.com/artic…
For more information, please contact Melody Bauer at [email protected].
#RareDisease #PatientCenteredOutcomeMeasures #ClinicalOutcomeAssessments
Interested in Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA) clinical trials and patient-centered outcome measures? Please see our Spotlight On: modusoutcomes.com/spotlight-…
#PatientCenteredOutcomes #ClinicalTrials #Duchenne #SpinalMuscularAtrophy
Interested in learning more about the interpretation and meaning of patient-reported outcome results? Here is Part 3 of 4 of @ModusOutcomes Q&A session on our reflections of the @FDAcdrhIndustry's Virtual Public Meeting held in the Fall 2020: youtube.com/watch?v=AJ-q-5Cu…
#PROs #MDDT
@ModusOutcomes is proud to be an official member of the @SISAQOL-IMI consortium made up of key stakeholders representing industry, academia, non-profit associations, cancer institutes, regulators, and patient advocacy organizations.
eortc.org/blog/2021/02/17/pr…
This global research initiative will contribute to improving the design and interpretation of statistical analyses of patient-reported outcome endpoints of clinical trials of new cancer-focused therapies.
#CancerResearch #PRO #ThoroughYetUseful
Interested in the use of Patient Reported Outcomes in Medical Device Evaluation? Here is Part 1 of 4 of @ModusOutcomes Q&A session on our reflections of the @FDAcdrhIndustry’s Virtual Public Meeting held in the Fall 2020: youtu.be/DuK_19vvV_A
#PROs #MedicalDevice #MDDT
Best wishes for 2021 from the @ModusOutcomes team! Thank you for a productive 2020. We look forward to continuing to work with you in the new year to measure what matters to patients.
youtu.be/OhdAAReziF4
#HappyNewYear #PatientCenteredOutcomes #ConceptDrivenMeasurement
@ModusOutcomes will present two posters on the #PRO results of two hematological cancer clinical trials conducted with @GSK and @TakedaPharma at the 62nd @ASH_hematology Annual Meeting and Exposition taking place on December 5-8.
Register now for #ASH20: hematology.org/meetings/annu…
@ModusOutcomes' @A_Regnault_PhD will outline in a multi-stakeholder session at @DrugInfoAssn's Advancing Patient Science Workshop how concept-driven measurement and mixed methods research can increase the value of PROs in clinical trials and healthcare decision-making.
Registration details for Session 5: Multi-Stakeholder Perspectives on Value and Future of PROs in Clinical Trials (December 4, 14:00-16:30 CET), chaired by @DrThomasMorel, can be found here: diaglobal.org/en/conference-…
#ModusOutcomes #PatientReportedOutcomes #GoodEnoughIsNotEnough
This year's @ISOQOL is an opportunity for @ModusOutcomes to showcase our commitment to unlock methodological challenges and help our clients in their high-stakes decisions.
#InsatiableCuriosity
Catch @A_Regnault_PhD and Juliette Meunier this afternoon as they present their research for @biogen on the interpretation of PerfO at the #ISOQOL Cutting Edge Research Plenary.
Learn more here: isoqol.org/events/27th-annua…
#ThoroughYetUseful